These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15799093)

  • 1. The trials of tenofovir trials.
    Lancet; 2005 Mar 26-Apr 1; 365(9465):1111. PubMed ID: 15799093
    [No Abstract]   [Full Text] [Related]  

  • 2. Unethical clinical trials in Thailand: a community response.
    Jintarkanon S; Nakapiew S; Tienudom N; Suwannawong P; Wilson D
    Lancet; 2005 May 7-13; 365(9471):1617-8. PubMed ID: 15885287
    [No Abstract]   [Full Text] [Related]  

  • 3. Unethical clinical trials in Thailand: a community response.
    Loff B; Jenkins C; Ditmore M; Overs C; Barbero R
    Lancet; 2005 May 7-13; 365(9471):1618-9. PubMed ID: 15889464
    [No Abstract]   [Full Text] [Related]  

  • 4. AIDS clinical trials. More woes for novel HIV prevention approach.
    Cohen J
    Science; 2005 Mar; 307(5716):1708. PubMed ID: 15774734
    [No Abstract]   [Full Text] [Related]  

  • 5. AIDS drug trial turned away; protests by prostitutes in Cambodia ended Tenofovir testing.
    Cha AE
    Washington Post; 2006 May; ():A10, A14. PubMed ID: 16856292
    [No Abstract]   [Full Text] [Related]  

  • 6. Disinhibition and risk compensation: scope, definitions, and perspective.
    Hogben M; Liddon N
    Sex Transm Dis; 2008 Dec; 35(12):1009-10. PubMed ID: 18936724
    [No Abstract]   [Full Text] [Related]  

  • 7. Women testing tenofovir for HIV prevention.
    AIDS Patient Care STDS; 2005 Feb; 19(2):128. PubMed ID: 15747428
    [No Abstract]   [Full Text] [Related]  

  • 8. [Introduction. Tenofovir].
    Mallolas J
    Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():1. PubMed ID: 19195430
    [No Abstract]   [Full Text] [Related]  

  • 9. AIDS research. Cambodian leader throws novel prevention trial into limbo.
    Cohen J
    Science; 2004 Aug; 305(5687):1092. PubMed ID: 15326323
    [No Abstract]   [Full Text] [Related]  

  • 10. [Conclusions. Tenofovir].
    Mallolas J
    Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():62-4. PubMed ID: 19195439
    [No Abstract]   [Full Text] [Related]  

  • 11. [3 years' data of tenofovir. Confirmed as a valuable building block].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():30-1. PubMed ID: 15373042
    [No Abstract]   [Full Text] [Related]  

  • 12. A second chance for microbicides.
    Baleta A
    Lancet; 2007 Jul; 370(9581):17-8. PubMed ID: 17632853
    [No Abstract]   [Full Text] [Related]  

  • 13. Protease inhibitors and non-nucleoside reverse transcriptase inhibitors have a comparable effect on the CD4 cell change after switching to tenofovir-based regimens.
    van Leth F; Prins JM; Lange JM; Geerlings SE
    AIDS; 2005 Oct; 19(15):1722-3. PubMed ID: 16184059
    [No Abstract]   [Full Text] [Related]  

  • 14. AIDS. Promote HIV chemoprophylaxis research, don't prevent it.
    Grant RM; Buchbinder S; Cates W; Clarke E; Coates T; Cohen MS; Delaney M; Flores G; Goicochea P; Gonsalves G; Harrington M; Lama JR; MacQueen KM; Moore JP; Peterson L; Sanchez J; Thompson M; Wainberg MA
    Science; 2005 Sep; 309(5744):2170-1. PubMed ID: 16195446
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV pre-exposure prophylaxis in injecting drug users.
    Karim SS
    Lancet; 2013 Jun; 381(9883):2060-2. PubMed ID: 23769217
    [No Abstract]   [Full Text] [Related]  

  • 16. Less than the sum of its parts: failure of a tenofovir-abacavir-Lamivudine triple-nucleoside regimen.
    Kuritzkes DR
    J Infect Dis; 2005 Dec; 192(11):1867-8. PubMed ID: 16267755
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to Joep M. A. Lange.
    Ditmore M
    PLoS Med; 2005 Oct; 2(10):e347. PubMed ID: 16231980
    [No Abstract]   [Full Text] [Related]  

  • 18. The tenofovir pre-exposure prophylaxis trial in Thailand: researchers should show more openness in their engagement with the community.
    Chua A; Ford N; Wilson D; Cawthorne P
    PLoS Med; 2005 Oct; 2(10):e346. PubMed ID: 16231979
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings.
    Myers GM; Mayer KH
    AIDS Patient Care STDS; 2011 Feb; 25(2):63-71. PubMed ID: 21284497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral tenofovir arm of VOICE trial discontinued early.
    McEnery R
    IAVI Rep; 2011; 15(5):21. PubMed ID: 22121550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.